BioCentury
ARTICLE | Clinical News

Genaera starts Lomucin pivotal Phase II

April 19, 2005 12:53 AM UTC

GENR will start a double-blind pivotal Phase II trial of Lomucin talniflumate to treat cystic fibrosis (CF) this quarter. The primary endpoint of the European trial in 200 patients is Forced Expirator...